TESA / IPA Blend
Growth Hormone Blend - Tesamorelin + Ipamorelin co-formulated GH-research blend.
A co-formulated blend of a stabilized GHRH analog with a selective secretagogue, prepared for combined growth-hormone-axis research.
Pairing a stabilized GHRH analog with a selective secretagogue lets researchers study a longer-acting GHRH signal alongside ghrelin-receptor stimulation in one preparation. As with all blends, identity and purity are documented on the lot COA.
TESA / IPA Blend specifications
- Molecular formula
- Co-formulated blend
- Sequence
- Tesamorelin + Ipamorelin
- Residues
- Tesamorelin + Ipamorelin
- Presentation
- Lyophilized powder
- Documented purity
- 99.83% by HPLC
- Available sizes
- 15mg ($110)
- Archived COA lots
- 3
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Dual GH stimulation - Studied for combined GHRH-analog and secretagogue activity.
Reported mechanisms in the literature
- Dual GH stimulation - Combines a stabilized GHRH analog with a selective secretagogue, studied for combined GHRH-analog and ghrelin-receptor activity. (Combination research)
What TESA / IPA Blend is researched for
- Dual stimulation - Studied for a longer-acting GHRH signal paired with ghrelin-receptor stimulation. (Combination research)
- GH-axis research - Investigated for combined GH-axis endpoints in metabolic research. (Preclinical literature)
TESA / IPA Blend certificates of analysis on file
Every lot below was tested by an independent laboratory and the full report is published as a PDF. Purity is shown exactly as the report states it. The same records are searchable in the COA library and can be checked on the lot verification page.
| Lot | Tested | Size | Laboratory | HPLC purity | Identity | Certificate |
|---|---|---|---|---|---|---|
| GFQ4J8 | 21 Oct 2026 | 15mg | Freedom Diagnostics | 99.60% | Confirmed (LC-MS/MS) | COA PDF |
| TSIP14-052026-1 | 14 May 2026 | 14mg | Freedom Diagnostics | 99.71% | Confirmed (LC-MS/MS) | COA PDF |
| TSIP-02172026-J | 20 Feb 2026 | 14mg | Freedom Diagnostics | 99.83% | Confirmed (LC-MS/MS) | COA PDF |
Published literature on TESA / IPA Blend
The mechanisms above trace to peer-reviewed studies indexed on PubMed. These are independent third-party publications, not Aspect Peptides claims. Browse indexed research on PubMed.
TESA / IPA Blend frequently asked questions
What is the TESA / IPA blend?
A co-formulation of Tesamorelin (a stabilized GHRH analog) with Ipamorelin (a selective secretagogue), for combined growth-hormone-axis research.
Is it approved for human use?
No. It is a research material only.
How is it documented?
Each lot ships with its Certificate of Analysis.
Documented to 99.83% purity by HPLC · third-party COA every lot · from $110 · For laboratory research use only.
Related Growth Hormone compounds
- Tesamorelin - GHRH analog studied for growth-hormone-axis research.
- Ipamorelin - Selective GH secretagogue studied for receptor-selective GH release.
- CJC-1295 - GHRH analog studied for sustained GH signaling.
- CJC-1295 DAC - Long-acting GHRH analog with drug-affinity complex.
- Sermorelin - GHRH(1-29) fragment studied for GH-axis research.
- CJC / IPA Blend - CJC-1295 + Ipamorelin co-formulated GH-research blend.